Abstract
Young children contract as many as six to eight upper respiratory tract viral infections per year, and these infections frequently lead to secondary bacterial infections such as acute otitis media and sinusitis. Cefprozil is an orally active third generation cephalosporin which has demonstrated activity against the gram-positive organismsStreptococcus pyogenes,pneumoniae andagalactiae and against methicilin-susceptibleStaphylococcus aureus. Cefprozil is also active against variousgramves and certainanaerobic organisms, and is stable to hydrolysis by a number of β-lactamases. Present study is an effort to study the efficacy and safety of cefprozil in children with acute otitis media. Three hundred and thirty four children aged 6 months through 12 years with clinical symptoms and tympanic membrane signs of AOM received cefprozil 30 mg/kg/day in two divided doses per day for 10 days. Clinically, 96.6% patients were cured, 2.4% improved and there was failure of therapy in 1% of the patients. There was no need for any rescue medication and any change in antibiotic in any patient. A satisfactory bacteriological outcome was (i.e. cure, presumed cure, and cure plus reinfection with a different pathogen) was achieved in 95% of patients. In conclusion, cefprozil is a well tolerated and effective drug for acute otitis media in children. Moreover, its expanded spectrum of activity, ability to achieve adequate concentrations in tissues, suitability for twice-daily dosing, and proven tolerability suggest that it is a better alternative to agents conventionally used in acute otitis media
Similar content being viewed by others
References
Parsons DS, Wald ER. Otitis media and sinusitis: similar diseases.Otolaryngol Clin North Am 1996; 29:11–25.
Pichichero ME. Cefprozil and respiratory tract infections in children.Pediatr Infect Dis J 1998; 17: S53–54.
Rodriguez WJ, Shwartz RH, Thorne MM. Increasing incidence of penicillin and ampicillin-resistant middle ear pathogens.Pediatr Inf Dis J 1995; 14:1075–1078.
Pichichero ME, Pichichero CL. Persistent acute otitis media: causative pathogens.Pedaitr Inf Dis J 1995; 14:178–183.
Wiseman LR, Benfield P. Cefprozil: A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.Drugs 1993; 45(2) : 295–317.
DelaGarza CA, Nolen TM, Rogan MP. Cefprozil vs. erythromycin in streptococcal tonsillopharyngitis.Infections in Medicine 1992; 9(Suppl E): 8–20.
Barbarash RA, Solomon E, Thieneman Jr. A, Stricker WE, ScottJCet al. Cefprozil versus amoxicillin/clavulanate in mild to moderate lower respiratory tract infections. Infections in Medicine 1992; 9(Suppl E): 40–47.
Wilber RB, Hamilton H, Leroy A, Gres J, Durham SJet al. Cefprozil vs. cefaclor in the treatment of lower respiratory tract infections.Infections in Medicine 1992; 9(Suppl C): 45–46.
Solomon E, McCarty JM, Morman MR, Ginsberg D, Nolen TM,et al. Comparison of cefprozil and amoxicillin/clavulanate potassium in the treatment of skin and skin structure infections in adults.Advances in Therapy 1992; 9:156–165.
Iravani A, Doyle CA, Durham SJ, Wilber RB and The Cefprozil Multicentre Study Group. Cefprozil vs. cefaclor in the treatment of acute and uncomplicated urinary tract infections.Clinical Thearpeutics 1992; 14:314–326.
Shyu WC, Haddad J, Reilly Jet al. Penetration of cefprozil into middle ear fluid of patients with otitis media.Antimicrob Agents Chemother 1994; 38(9): 2210–2212.
R. Brooks GH, Morgantown WV. Cefprozil, a new cephalosporin: Its use in various clinical trials.Southern Medical Journal 1995; 88(3): 338–346.
In Bluestone CD and Klein JO, eds.Otitis Media in Infants and Children. Philadelphia. The WB Saunders Co., 1987.
Glebink GS. The microbiology of otitis media.Pedaitr Inf Dis 1989; 8: S18-S20.
Arguedas AG, Zaleska M, Stutman HR, Blumer JL, Hains CS. Comparative trial of cefprozil vs amoxicillin clavulanate potassium in the treatment of children with acute otitis media with edffusion.Pediatr Inf Dis J 1991b; 10: 375–380.
Aronovitz GH, Doyle CA, Durham SJet al. Cefprozil vs. amoxicillin/clavulanate in the treatment of acute otitis media. Infections in Medicine 1992; 9(suppl E): 40–47.
Poole JM, Rosenberg R, Aronovitz GHet al. Cefprozil versus cefixime and cefaclor in otitis media in children.Infections in Medicine 1992; 9(suppl E): 21–32.
In Sackett DL and Haynes RB, eds.Compliance with Therapeutic Regimens;Baltimore, MD: Johns Hopkins University Press, 1976, 293p.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, N., Bagga, V., Parmar, B.J. et al. Efficacy and tolerability assessment of cefprozil in children with acute otitis media. Indian J Pediatr 71, 319–324 (2004). https://doi.org/10.1007/BF02724098
Issue Date:
DOI: https://doi.org/10.1007/BF02724098